Table 4 Response to antiviral treatment... | American Society of Hematology

Table 4

Response to antiviral treatment of chronic hepatitis C

Reference	No. of patients	Status of patients	Treatment	Therapy, mo	SVR, %
80	51	Naive	Interferon-α monotherapy	15	37
78	70	Naive	Interferon-α monotherapy	12	40
81	13	Naive	Interferon-α monotherapy	18	75
34	28	Naive	Interferon-α monotherapy	6	28
83	89	Naive	Interferon-α monotherapy	12	52
84	10	Naive	Interferon-α monotherapy	12	80
87	11	No responders or relapsers	Interferon-α + ribavirin	6	45
86	18	Naive	Interferon-α + ribavirin	12	72
88	3	Naive	Interferon-α + ribavirin	12	100
85	5	Naive	Interferon-α + ribavirin	12	80
90	12	Naive	Peg-Interferon monotherapy	12	33
90	8	Naive	Peg-Interferon + ribavirin	12	63
32	39	Naive	Peg-Interferon monotherapy	12	46
32	39	Naive	Peg-Interferon + ribavirin	12	64
91	4 (genotypes 2, 3)	Naive	Peg-Interferon + ribavirin	6	25
91	12 (genotypes 1-4)	Naive	Peg-Interferon + ribavirin	12	50

Reference	No. of patients	Status of patients	Treatment	Therapy, mo	SVR, %
80	51	Naive	Interferon-α monotherapy	15	37
78	70	Naive	Interferon-α monotherapy	12	40
81	13	Naive	Interferon-α monotherapy	18	75
34	28	Naive	Interferon-α monotherapy	6	28
83	89	Naive	Interferon-α monotherapy	12	52
84	10	Naive	Interferon-α monotherapy	12	80
87	11	No responders or relapsers	Interferon-α + ribavirin	6	45
86	18	Naive	Interferon-α + ribavirin	12	72
88	3	Naive	Interferon-α + ribavirin	12	100
85	5	Naive	Interferon-α + ribavirin	12	80
90	12	Naive	Peg-Interferon monotherapy	12	33
90	8	Naive	Peg-Interferon + ribavirin	12	63
32	39	Naive	Peg-Interferon monotherapy	12	46
32	39	Naive	Peg-Interferon + ribavirin	12	64
91	4 (genotypes 2, 3)	Naive	Peg-Interferon + ribavirin	6	25
91	12 (genotypes 1-4)	Naive	Peg-Interferon + ribavirin	12	50